Condition: Thyroid Diseases · Congenital Hypothyroidism · Graves Disease · Sponsor: University Children's Hospital Basel
The aim of this multicentric, randomised, two-arms and single-blinded clinical trial is to prospectively evaluate OptiThyDose for Congenital hypothyroidism (CH) and Graves' disease (GD).
This description comes directly from the study's public registry record.
Gabor Szinnai, Prof. MD, PhD · +41 61 704 29 22 · Gabor.Szinnai@ukbb.ch
Always discuss trial participation with your own doctor first.
| Department of Paediatric Endocrinology, Diabetology and Gynaecology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris | Paris, France | Not Yet Recruiting |
| Paediatric Endocrinology and Diabetology, University Children's Hospital Basel (UKBB) | Basel, Canton of Basel-City, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06864351